BRAFV600E monitoring in blood is increasingly used for establishing histiocytosis diagnosis or evaluation of responses to therapy. In this webinar, analytic details and methods for validation of commercial or inhouse developed PCR platforms will be presented and discussed.
Speakers include:
Office: +1 (856) 589-6606Fax: +1 (856) 589-6614Email: [email protected]
Histiocyte Society 332 N Broadway Pitman, NJ 08071 USA